Kazia Therapeutics (KZIA) Shares Outstanding (Diluted Average) (2016 - 2024)
Kazia Therapeutics (KZIA) posted Shares Outstanding (Diluted Average) of $1608.1 for Q4 2024, down 32.87% on a QoQ basis from $2395.6 in Q4 2023, and down 32.87% year-over-year from $2395.6 in Q1 2024.
Kazia Therapeutics (KZIA) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $1608.1 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 810.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 256.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 138.23 Mn |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,608.08 |
| Dec 31, 2023 | 2,395.64 |
| Dec 31, 2022 | 6,128.04 |
| Dec 31, 2020 | 78.52 Mn |
| Dec 31, 2019 | 44.74 Mn |
| Dec 31, 2017 | 675.98 |
| Dec 31, 2016 | 33.95 Mn |